NCT05234541

Brief Summary

To investigate the value of the cut-off perfusion index showing that the block is successful in infraclavicular blocks performed under ultrasound guidance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 1, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 10, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2022

Completed
Last Updated

February 10, 2022

Status Verified

July 1, 2021

Enrollment Period

10 months

First QC Date

February 1, 2022

Last Update Submit

February 1, 2022

Conditions

Upper Extremity Surgery

Keywords

infraclavicular block, perfusion index

Outcome Measures

Primary Outcomes (1)

  • To Investigate the Value of the Cut-off Perfusion Index Showing That the Block is Successful in Infraclavicular Blocks Performed Under Ultrasound Guidance

    To measure perfusion index values in patients aged 18-65 years who underwent upper extremity surgery

    Perfusion index, pulse and blood pressure will be measured 5-10-20 minutes after the block is made.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ASA1-2 50 PATIENTS BETWEEN 18-65 YEARS

You may qualify if:

  • ASA 1-2 PATIENTS
  • PATIENTS BETWEEN 18-65 YEARS
  • PATIENTS WITH INFRACLAVICULAR BLOCK

You may not qualify if:

  • ASA3-4 PATIENTS
  • PATIENTS UNDER THE AGE OF 18, PATIENTS OVER 65
  • PATIENTS WHO DO NOT WANT TO BE INCLUDED IN THE STUDY
  • PATIENTS WITH CONTRAINDICATION TO INFRACLAVICULAR BLOCK
  • PATIENTS WITHOUT COOPERATION
  • PATIENTS WITH DIABETES MELLITUS
  • THOSE WHO HAVE PERIPHERAL ARTERY DISEASE

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adıyaman University Recruitment

Adıyaman, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

February 1, 2022

First Posted

February 10, 2022

Study Start

July 1, 2021

Primary Completion

April 15, 2022

Study Completion

November 15, 2022

Last Updated

February 10, 2022

Record last verified: 2021-07

Locations

TU(1)